News for hackers. Stuff that matters.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by JumpCrisscross on Monday July 12, 2021 @02:08AM (#27807554)
> Europe does drug R&D and still manages to sell their drugs at a reasonable price to sick people

Most novel R&D, in America and Europe, happens in biotech. (“Big” pharma does trials, manufacturing scaling and distribution.) The investment thesis for most of this research does not work without the American market.

This doesn’t mean high drug prices are a necessity. Just that the funding needs to be replaced if we want to preserve innovation.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by m12k on Monday July 12, 2021 @07:47AM (#27809305)
But to be fair, the US pharma sector spends roughly as much on marketing as it does on R&D. And a huge chunk of that R&D budget goes into analogue drugs to either sidestep patents from rivals or maintain profit margins when their own patents expire (they can then use that huge marketing budget to get the newly patented drug to take over for the old one with the nearly-expired patent, despite small or non-existent benefits from a medical perspective). So long story short, there's a pretty good case to be made that public research with somewhere between 1/10th and 1/5th the budget of big pharma is all it takes to match or overtake them in innovation, as measured by actual benefit to the patients.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by AnthonyMouse on Monday July 12, 2021 @01:11PM (#27812559)
> But to be fair, the US pharma sector spends roughly as much on marketing as it does on R&D.

Spending money on marketing lowers prices by increasing volumes.

If you spend a billion dollars on R&D and then spend nothing on marketing and sell to 200,000 customers, they would each have to pay $5000 to fund the R&D. If you spend a billion dollars on R&D and two billion dollars on marketing and sell to a million customers, they would each have to pay $3000 to fund both the R&D and the marketing.

And it also does something useful, assuming the new drug is actually beneficial, by making people aware of the existence of something that would make their lives better. It helps no one to invent a great new thing that then nobody uses because nobody knows it exists.

> And a huge chunk of that R&D budget goes into analogue drugs to either sidestep patents from rivals or maintain profit margins when their own patents expire (they can then use that huge marketing budget to get the newly patented drug to take over for the old one with the nearly-expired patent, despite small or non-existent benefits from a medical perspective).

It doesn't actually cost that much to do that because you already know what you're looking for in that case. It's the real R&D that costs money.

> So long story short, there's a pretty good case to be made that public research with somewhere between 1/10th and 1/5th the budget of big pharma is all it takes to match or overtake them in innovation, as measured by actual benefit to the patients.

The biggest problem with public research funding is how to allocate it.

With a profit motive and market competition, the people who allocate research funding inefficiently go out of business and the people who allocate it well make a lot of money, and then have more money to fund more research.

Without that, research funding turns into defense contracting and then we waste trillions of dollars and have nothing to show for it. Or worse, politicians say we'll only need 1/10th of the budget even though the incentives aren't actually there to improve efficiency, and then we get 1/10th of the research.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by frenchy on Monday July 12, 2021 @04:48PM (#27814924)
> Spending money on marketing lowers prices by increasing volumes.

That explains why they do it, but not why it's useful to the public. Marketing isn't necessarily a zero sum game, but it in the case of direct-to-consumer drug advertisments, it's pretty close.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by sangnoir on Tuesday July 13, 2021 @09:56AM (#27821002)
> Spending money on marketing lowers prices by increasing volumes.

Do you have any proof of this - had you said it increases profits - I'd have readily agreed with you.

> If you spend a billion dollars on R&D and then spend nothing on marketing and sell to 200,000 customers, they would each have to pay $5000 to fund the R&D. If you spend a billion dollars on R&D and two billion dollars on marketing and sell to a million customers, they would each have to pay $3000 to fund both the R&D and the marketing.

Or, in line with their "fiduciary duty to shareholders", the company still sells at $5000 to a million customers: see Martin Shkreli, Epipens, or dozens of other real-life examples that prove your lower-price hypothesis wrong. Without competition, drug manufacturers have no incentive to lower prices when they can make more profits instead.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by mnowicki on Wednesday July 14, 2021 @12:11PM (#27834711)
Spending money on marketing MIGHT lower prices when looking at a single company.

For a market like pharmaceuticals where patients are prescribed by Dr's and are going to be subscribed one thing or another regardless, the lack of any marketing wouldn't really reduce the amount of volume in the industry as a whole, might just switch around which drugs/companies it goes to.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by simonh on Monday July 12, 2021 @04:41AM (#27808308)
That's fair enough, maybe Europeans should pay more than they do for pharmaceuticals and get away with paying less due to the huge profits Pharma makes out of the US health care system.

That's not really on Europe though. It's for the US to sort out it's horrifically dysfunctional health care system, if it chooses to. Honestly I don't know if what Biden plans to do, particularly in relation to Big Pharma is reasonable. I suspect it's likely to be treating the symptoms with regulation rather than the disease through reform, but maybe that's what you do when treating the disease runs into insurmountable political resistance.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by guiriduro on Monday July 12, 2021 @09:06AM (#27809825)
Political resistance is the disease.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by bigbizisverywyz on Monday July 12, 2021 @07:34AM (#27809233)
MY understanding (at least in the UK) was that hospitals and universities also do a lot of research (often cutting-edge), and are often the source of innovation. These entities are largely publicly funded.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by pclmulqdq on Monday July 12, 2021 @07:51AM (#27809332)
Most drugs appear first in publicly-funded research, but so does every other compound that can get past a p value of 0.05.

The main value proposition of big pharma is that they take those results, find the ones that actually work (very few of them do), study them for side effects, and characterize them. There is a LOT of work between the published research and an actual drug (there is actually significantly more risk and cost to go from a paper to a drug than to write the initial paper).

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by herbst on Tuesday July 13, 2021 @08:29AM (#27820103)
Do you have a source for that? It's kinda hard to believe that America happily is paying the research for the world for so long without trump (or anyone) making a huge deal out of it.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by hellbannedguy on Monday July 12, 2021 @04:47AM (#27808339)
China, and Russia, and other countries, are making big breakthroughs in biotech, but we are hesitant on believing their results--now.

They have the advantage of pushing through Clinical trials without much oversight.

I am all for strict Clinical trial protocols, but our biotech companies are testing their drugs in countries that don't have strict protocols on safety.

I don't get the price increase argument anymore. The biotech companies are multinational. It's just Americans give them the most money.

I'm getting afraid of the whole, "American biotech will cure anything because of the financial perks they get" mantra too.

I pay out of pocket for my needs at Costco. Their prices are a bit above wholesale. That said, I pay way to much for certain drugs. I guarantee their are shinagigans going on in the pricing if certain drugs.

Bupenorpine us a generic drug. Why gave I been paying $70 for a decade?

(This drug is America's answer to the opioid crisis. I was prescribed this drug off label for another condition. It's the price that has me scratching my head. It's been the same price for too long. Other pharmacy's price it higher.)

I won't get started on the drugs (new--not genetic) prescribed for depression. And then reading Irving Kirsch's research. His paper can be found, but you need to hunt for it. I'll offer this interview.

https://www.aarp.org/health/drugs-supplements/info-05-2010/d...

I am proud of Biden's promise to lower prices. I am so glad he's at the helm. I'm not being overly political. I just am just at bit hopeful now. Something I haven't been in 4 plus years.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by BobbyJo on Monday July 12, 2021 @10:19AM (#27810535)
> They have the advantage of pushing through Clinical trials without much oversight.

This isn't an advantage. What you end up with is a lack of clarity on what works well, what doesn't, and why. It makes it easy to go from A to B, a hypothesis to a drug, but it clouds what C, D, and E should be, as that lack of oversight turns into a lack of deeper insight.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by IfOnlyYouKnew on Monday July 12, 2021 @07:04AM (#27809068)
To get approval in US and Europe, the trials need to be of the same quality no matter where they are run. Sometimes it may be cheaper in poorer countries because you don't have to pay your volunteers as much. You still need to check all the appropriate boxes regarding informed consent as anywhere else. And, of course, western companies are entirely capable to run trials anywhere in the world. The COVID vaccine trials were run in Europe, the US, South Africa, Israel, and really any place where the incidence was high enough.

And China and Russia are not "making big breakthroughs": just look at the vaccines again: BioNTech/Moderna/J&J/AZ all work extremely well, all things considered. The Russian and Chinese vaccines don't. Just ask/look at the charts of Chile. Or any Russian.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by Monory on Monday July 12, 2021 @10:32AM (#27810669)
Am Russian, am vaccinated with Sputnik V, would do it again. Yes, the study was rushed and details were missing, but, eventually, all things got in order.

And it's a real working vaccine, effects of which I see basically every day on my friends.

Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by acdha on Monday July 12, 2021 @12:20PM (#27811867)
Yes: unless a vaccine is harmful, it’s better to have than not. Higher effectiveness is better, of course, but if there was ever a time to say “don’t let perfect be the enemy of good”, it’s during a raging pandemic.
Re:Biden launches action on "Big Tech, Big Pharma, and Big A... by JumpCrisscross on Tuesday July 13, 2021 @04:35AM (#27818737)
> it's a real working vaccine

It is better than nothing. But it’s a far cry from the best vaccines (Pfizer, Moderna, and to a lesser degree, AstraZeneca), which protect against novel variants and can produce some level of herd immunity.